Catterall WA, Perez-Reyes E, Snutch TP, Striessnig J (2006). “International Union of Pharmacology. XLVIII. Nomenclature and structure-function relationships of voltage-gated calcium channels.”. Pharmacol. Rev.57 (4): 411–25. doi:10.1124/pr.57.4.5. PMID16382099.
Rotman EI, De Jongh KS, Florio V, et al. (1992). “Specific phosphorylation of a COOH-terminal site on the full-length form of the alpha 1 subunit of the skeletal muscle calcium channel by cAMP-dependent protein kinase.”. J. Biol. Chem.267 (23): 16100–5. PMID1322891.
Röhrkasten A, Meyer HE, Nastainczyk W, et al. (1988). “cAMP-dependent protein kinase rapidly phosphorylates serine- 687 of the skeletal muscle receptor for calcium channel blockers.”. J. Biol. Chem.263 (30): 15325–9. PMID2844809.
Tanabe T, Takeshima H, Mikami A, et al. (1987). “Primary structure of the receptor for calcium channel blockers from skeletal muscle.”. Nature328 (6128): 313–8. doi:10.1038/328313a0. PMID3037387.
Hogan K, Powers PA, Gregg RG (1995). “Cloning of the human skeletal muscle alpha 1 subunit of the dihydropyridine-sensitive L-type calcium channel (CACNL1A3).”. Genomics24 (3): 608–9. doi:10.1006/geno.1994.1677. PMID7713519.
Elbaz A, Vale-Santos J, Jurkat-Rott K, et al. (1995). “Hypokalemic periodic paralysis and the dihydropyridine receptor (CACNL1A3): genotype/phenotype correlations for two predominant mutations and evidence for the absence of a founder effect in 16 caucasian families.”. Am. J. Hum. Genet.56 (2): 374–80. PMID7847370.
Boerman RH, Ophoff RA, Links TP, et al. (1995). “Mutation in DHP receptor alpha 1 subunit (CACLN1A3) gene in a Dutch family with hypokalaemic periodic paralysis.”. J. Med. Genet.32 (1): 44–7. doi:10.1136/jmg.32.1.44. PMID7897626.
Gregg RG, Couch F, Hogan K, Powers PA (1993). “Assignment of the human gene for the alpha 1 subunit of the skeletal muscle DHP-sensitive Ca2+ channel (CACNL1A3) to chromosome 1q31-q32.”. Genomics15 (1): 107–12. doi:10.1006/geno.1993.1017. PMID7916735.
Drouet B, Garcia L, Simon-Chazottes D, et al. (1994). “The gene coding for the alpha 1 subunit of the skeletal dihydropyridine receptor (Cchl1a3 = mdg) maps to mouse chromosome 1 and human 1q32.”. Mamm. Genome4 (9): 499–503. doi:10.1007/BF00364784. PMID8118099.
Iles DE, Segers B, Olde Weghuis D, et al. (1994). “Refined localization of the alpha 1-subunit of the skeletal muscle L-type voltage-dependent calcium channel (CACNL1A3) to human chromosome 1q32 by in situ hybridization.”. Genomics19 (3): 561–3. doi:10.1006/geno.1994.1106. PMID8188298.
O'Brien RO, Taske NL, Hansbro PM, et al. (1996). “Exclusion of defects in the skeletal muscle specific regions of the DHPR alpha 1 subunit as frequent causes of malignant hyperthermia.”. J. Med. Genet.32 (11): 913–4. doi:10.1136/jmg.32.11.913. PMID8592342.
Hogan K, Gregg RG, Powers PA (1997). “The structure of the gene encoding the human skeletal muscle alpha 1 subunit of the dihydropyridine-sensitive L-type calcium channel (CACNL1A3).”. Genomics31 (3): 392–4. doi:10.1006/geno.1996.0066. PMID8838325.
Robinson RL, Monnier N, Wolz W, et al. (1997). “A genome wide search for susceptibility loci in three European malignant hyperthermia pedigrees.”. Hum. Mol. Genet.6 (6): 953–61. doi:10.1093/hmg/6.6.953. PMID9175745.
Monnier N, Procaccio V, Stieglitz P, Lunardi J (1997). “Malignant-hyperthermia susceptibility is associated with a mutation of the alpha 1-subunit of the human dihydropyridine-sensitive L-type voltage-dependent calcium-channel receptor in skeletal muscle.”. Am. J. Hum. Genet.60 (6): 1316–25. doi:10.1086/515454. PMID9199552.
Meyers MB, Puri TS, Chien AJ, et al. (1998). “Sorcin associates with the pore-forming subunit of voltage-dependent L-type Ca2+ channels.”. J. Biol. Chem.273 (30): 18930–5. doi:10.1074/jbc.273.30.18930. PMID9668070.
Morrill JA, Brown RH, Cannon SC (1999). “Gating of the L-type Ca channel in human skeletal myotubes: an activation defect caused by the hypokalemic periodic paralysis mutation R528H.”. J. Neurosci.18 (24): 10320–34. PMID9852570.
Protasi F, Paolini C, Nakai J, et al. (2003). “Multiple regions of RyR1 mediate functional and structural interactions with alpha(1S)-dihydropyridine receptors in skeletal muscle.”. Biophys. J.83 (6): 3230–44. doi:10.1016/S0006-3495(02)75325-3. PMID12496092.
Carsana A, Fortunato G, De Sarno C, et al. (2003). “Identification of new polymorphisms in the CACNA1S gene.”. Clin. Chem. Lab. Med.41 (1): 20–2. doi:10.1515/CCLM.2003.004. PMID12636044.